Botulinum Toxin B; The New Option in Cosmetic Injection
May 2005 | Volume 1 | Issue 1 | Original Article | 17 | Copyright © 2005
James M. Spencer, MD, MS
Botulinum toxin, one of the nature's most toxic substances, is the unlikely source of one of cosmetic dermatology's most popular new injectable treatment options. The article describes the physiological and biological workings of the several structurally similar but antigenically distinct serotypes of botulinum toxin, and provides clinical studies comparing and contrasting the key ingredients in Botox, Dysport, and Myobloc (Neurobloc).
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close